Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

2.

Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.

Israili ZH.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S73-86. Review.

PMID:
10854085
3.

Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.

Kjeldsen SE, Os I, Høieggen A, Beckey K, Gleim GW, Oparil S.

Am J Cardiovasc Drugs. 2005;5(1):17-22. Review.

PMID:
15631534
4.

Telmisartan/hydrochlorothiazide: a new fixed dose combination.

Maillard M, Burnier M.

Expert Rev Cardiovasc Ther. 2005 May;3(3):375-86. Review.

PMID:
15889965
5.

The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.

Greathouse MK, Weir MR.

Postgrad Med. 2012 Mar;124(2):40-52. doi: 10.3810/pgm.2012.03.2535. Review.

PMID:
22437214
6.
7.

Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.

Kolasinska-Malkowska K, Filipiak KJ, Gwizdala A, Tykarski A.

Expert Rev Cardiovasc Ther. 2008 Jun;6(5):759-71. doi: 10.1586/14779072.6.5.759. Review.

PMID:
18510491
8.

Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.

Al Khalaf MM, Thalib L, Doi SA.

Am J Cardiovasc Drugs. 2009;9(1):29-43. doi: 10.2165/00129784-200909010-00004. Review.

PMID:
19178130
9.
10.

Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension.

Schmieder RE.

Expert Opin Pharmacother. 2004 Nov;5(11):2303-10. Review.

PMID:
15500377
11.

Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertension.

Salerno CM, Demopoulos L, Mukherjee R, Gradman AH.

J Clin Hypertens (Greenwich). 2004 Nov;6(11):614-20.

12.

Valsartan plus hydrochlorothiazide for first-line therapy in hypertension.

Lacourcière Y, Poirier L, Samuel R.

Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1491-501. doi: 10.1586/erc.09.140. Review.

PMID:
19954310
13.

Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy.

Kim KS, Fan WH, Kim YD, Zhu W, Ngau YY, Tong P, Kim BS, Santos M, Lin WH, Buranakitjaroen P, Massaad R, Smith RD; Asia HEAALTH Study Investigators.

Hypertens Res. 2009 Jun;32(6):520-6. doi: 10.1038/hr.2009.42. Epub 2009 Apr 24.

PMID:
19390542
14.

Metabolic syndrome: treatment of hypertensive patients.

Israili ZH, Lyoussi B, Hernández-Hernández R, Velasco M.

Am J Ther. 2007 Jul-Aug;14(4):386-402. Review.

PMID:
17667215
15.

Fixed combination therapy of hypertension: focus on valsartan/hydrochlorothiazide combination (Diovan/HCT).

Chrysant SG.

Expert Rev Cardiovasc Ther. 2003 Sep;1(3):335-43. Review.

PMID:
15030262
16.
17.

Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.

Abe M, Okada K, Matsumoto K.

Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1285-303. doi: 10.1517/17425250903282799. Review.

PMID:
19761411
18.

Supplemental Content

Support Center